To address the above issues, we investigated the expression of p65 and p‐p105 in patients with surgically resectable NSCLC and the association between clinicopathological characteristics, overall survival and the expression of p65 and p‐p105. This evidence concerns the gene NFKB2 and non-small cell lung carcinoma.